Olanzapine Cristers Pharma

Olanzapine, the active ingredient in Olanzapine Cristers Pharma, is an atypical antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults. GNH USA supplies Olanzapine Cristers Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olanzapine Cristers Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olanzapine is an atypical antipsychotic that acts on dopamine and serotonin pathways to treat several psychiatric conditions.

- Schizophrenia: reduces psychotic symptoms such as delusions, hallucinations and thought disorder. - Bipolar I Disorder (Manic Phase): controls acute manic episodes and helps maintain mood stability. - Bipolar I Disorder (Depressive Phase): used as part of combination therapy to alleviate depressive symptoms. - Schizoaffective Disorder: improves both psychotic and mood components of the illness. - Psychotic Depression: adjunctive therapy for major depressive disorder with psychotic features. - Tourette Syndrome: may reduce the frequency and severity of motor and vocal tics. - Autism Spectrum Disorders: helps in managing irritability and aggression associated with ASD.

Olanzapine may cause a range of adverse reactions, most of which are dose‑dependent and reversible upon discontinuation.

Common Side Effects: - Weight gain: increased appetite and caloric intake. - Sedation: drowsiness or feeling of tired tired tired tired torth - Dry mouth: - Constipation: - Elevated blood glucose: mild hyper‑glycaemia. - Dizziness:

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: high fever   the   t   t   t  \

Olanzate  

-   a   t  t -   t -  t -  t -  -  t -  t  t -  t  -  t -  t -  -  t -  -  -  -  t  -  t - y  t -  t -  y -  -  -  -  t -  -  y -  -   -  t -  -  t -  -  -  t -  -  t -  - ",